These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30979007)

  • 41. Cannabinoid receptors and their ligands.
    Pertwee RG; Ross RA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells.
    Sieczkowski E; Lehner C; Ambros PF; Hohenegger M
    Int J Cancer; 2010 May; 126(9):2025-35. PubMed ID: 19739078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
    Li JG; Chen C; Liu-Chen LY
    Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
    Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation of intrahepatic membrane-bound and secretory apolipoprotein B by monoclonal antibodies: membrane-bound apolipoprotein B is more glycosylated.
    Wong L; Torbati A
    Biochemistry; 1994 Feb; 33(7):1923-9. PubMed ID: 8110797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycosylation of CD4. Tunicamycin inhibits surface expression.
    König R; Ashwell G; Hanover JA
    J Biol Chem; 1988 Jul; 263(19):9502-7. PubMed ID: 3259951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct mechanism of cell death is responsible for tunicamycin-induced ER stress in SK-N-SH and SH-SY5Y cells.
    Oda T; Kosuge Y; Arakawa M; Ishige K; Ito Y
    Neurosci Res; 2008 Jan; 60(1):29-39. PubMed ID: 18029041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.
    el Battari A; Forget P; Fouchier F; Pic P
    Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):527-33. PubMed ID: 1654885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppressive effect of nobiletin, a citrus polymethoxyflavonoid that downregulates thioredoxin-interacting protein expression, on tunicamycin-induced apoptosis in SK-N-SH human neuroblastoma cells.
    Ikeda A; Nemoto K; Yoshida C; Miyata S; Mori J; Soejima S; Yokosuka A; Mimaki Y; Ohizumi Y; Degawa M
    Neurosci Lett; 2013 Aug; 549():135-9. PubMed ID: 23774476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of endocannabinoids and endovanilloids in Ca2+ signalling.
    De Petrocellis L; Di Marzo V
    Cell Calcium; 2009 Jun; 45(6):611-24. PubMed ID: 19356798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological tools in endocannabinoid neurobiology.
    Mor M; Lodola A
    Curr Top Behav Neurosci; 2009; 1():87-110. PubMed ID: 21104381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.
    Appendino G; Ligresti A; Minassi A; Cascio MG; Allarà M; Taglialatela-Scafati O; Pertwee RG; De Petrocellis L; Di Marzo V
    J Med Chem; 2009 May; 52(9):3001-9. PubMed ID: 19361197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    Oesch S; Gertsch J
    J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of tunicamycin on growth hormone binding in rat adipocytes.
    Szecowka J; Tai LR; Goodman HM
    Endocrinology; 1990 Apr; 126(4):1834-41. PubMed ID: 2318146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BfCBR: a cannabinoid receptor ortholog in the cephalochordate Branchiostoma floridae (Amphioxus).
    Elphick MR
    Gene; 2007 Sep; 399(1):65-71. PubMed ID: 17553639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor.
    Bisello A; Greenberg Z; Behar V; Rosenblatt M; Suva LJ; Chorev M
    Biochemistry; 1996 Dec; 35(49):15890-5. PubMed ID: 8961954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.
    Yoo J; Mashalidis EH; Kuk ACY; Yamamoto K; Kaeser B; Ichikawa S; Lee SY
    Nat Struct Mol Biol; 2018 Mar; 25(3):217-224. PubMed ID: 29459785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.